Palbociclib and Letrozole in Advanced Breast CancerRichard S. Finn, Dennis J. Slamon, Nadia Harbeck et al.|New England Journal of Medicine|2016Cited by 2.9k
Palbociclib in Hormone-Receptor–Positive Advanced Breast CancerNicholas C. Turner, Massimo Cristofanilli, Jungsil Ro et al.|New England Journal of Medicine|2015Cited by 1.6k
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion studyNehal J. Lakhani, Wells A. Messersmith, Laura Q.M. Chow et al.|Seoul National University Open Repository (Seoul National University)|2021Cited by 95